Health3 years ago
FDA Agree To New Imaging Medicine To Assist Recognize Ovarian Cancer Lesions
The U.S. Food and Drug Administration today endorsed Cytalux (pafolacianine), an imaging drug expected to help specialists in distinguishing ovarian disease injuries. The medication is intended...
